These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28968650)

  • 1. Response to comments on 'Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study'.
    Amitay EL; Brenner H
    Carcinogenesis; 2018 Jan; 39(1):85. PubMed ID: 28968650
    [No Abstract]   [Full Text] [Related]  

  • 2. Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study.
    Amitay EL; Werner S; Vital M; Pieper DH; Höfler D; Gierse IJ; Butt J; Balavarca Y; Cuk K; Brenner H
    Carcinogenesis; 2017 Aug; 38(8):781-788. PubMed ID: 28582482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
    Leung A; Tsoi H; Yu J
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitation of intestinal Fusobacterium and butyrate- producing bacteria in patients with colorectal adenomas and colorectal cancer].
    Miao H; Wu N; Luan C; Yang X; Zhang R; Lv N; Zhu B
    Wei Sheng Wu Xue Bao; 2014 Oct; 54(10):1228-34. PubMed ID: 25803901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
    Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
    Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Screening Techniques for Colorectal Cancer All Have an 'A' Recommendation? No: When It Comes to Colorectal Cancer Screening, Test Choice Matters.
    Lin KW; Frost JL
    Am Fam Physician; 2017 May; 95(10):618-620. PubMed ID: 28671398
    [No Abstract]   [Full Text] [Related]  

  • 8. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
    Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
    Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Colorectal Cancer at Earlier Ages: Putting the Cart before the Horse.
    Braillon A
    Gastroenterology; 2019 Apr; 156(5):1532. PubMed ID: 30660728
    [No Abstract]   [Full Text] [Related]  

  • 11. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
    Bashir A; Miskeen AY; Hazari YM; Asrafuzzaman S; Fazili KM
    Tumour Biol; 2016 Mar; 37(3):2805-10. PubMed ID: 26718210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of low-penetrance alleles associated with colon cancer risk].
    Houlston R
    Med Sci (Paris); 2009 Mar; 25 Spec No 1():39-41. PubMed ID: 19361410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer: Hand-in-hand - colorectal cancer metastasizes with microorganisms.
    Yang Y; Jobin C
    Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):133-134. PubMed ID: 29339812
    [No Abstract]   [Full Text] [Related]  

  • 14. Fusobacterium and colorectal carcinogenesis.
    Güven DC; Dizdar O
    Carcinogenesis; 2018 Jan; 39(1):84. PubMed ID: 28968715
    [No Abstract]   [Full Text] [Related]  

  • 15. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome: Fusobacterium persistence in colorectal cancer.
    York A
    Nat Rev Microbiol; 2017 Dec; 16(1):2. PubMed ID: 29217844
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer-associated fecal microbial markers in colorectal cancer detection.
    Eklöf V; Löfgren-Burström A; Zingmark C; Edin S; Larsson P; Karling P; Alexeyev O; Rutegård J; Wikberg ML; Palmqvist R
    Int J Cancer; 2017 Dec; 141(12):2528-2536. PubMed ID: 28833079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Colonoscopy in the screening, follow-up and treatment of colorectal cancer and precursor lesions].
    Pellisé M
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():71-7. PubMed ID: 26520199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon cancer in Africa: Primetime for screening?
    May FP; Anandasabapathy S
    Gastrointest Endosc; 2019 Jun; 89(6):1238-1240. PubMed ID: 31104752
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of oncogenic bacteria with colorectal cancer in South China.
    Zhou Y; He H; Xu H; Li Y; Li Z; Du Y; He J; Zhou Y; Wang H; Nie Y
    Oncotarget; 2016 Dec; 7(49):80794-80802. PubMed ID: 27821805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.